Back to Sites

FAMCRU CRS

Site Number

8950

Address

FAMCRU
Ward J8
Tygerberg Hospital
Francie van Zijl Drive
Parow Valley
Tygerberg, Western Cape Province 7505
South Africa

IMPAACT Members at this Site

Jacqueline Jacobs CAB Member

Siphokazi Khonkwane CAB Member

Jeanne De Jager CRS Coordinator

Shaun Barnabas CRS Leader

Mark Cotton CRS Leader

Ronell Arendze CRS Staff

Jacky Crisp CRS Staff

Jeanne De Jager CRS Staff

Els Dobbels CRS Staff

George Fourie CRS Staff

Lindee Ganger CRS Staff

Leonie Groepies CRS Staff

Morne Isaacs CRS Staff

Veronica Matroos CRS Staff

Bongiwe Mbotho CRS Staff

Nwabisa Mtambeka CRS Staff

Susan Purchase CRS Staff

Helena Rabie CRS Staff

Magdel Rossouw CRS Staff

Kurt Smith CRS Staff

Marie Theunissen CRS Staff

Warren Zimri CRS Staff

Jeannine du Bois CTU Coordinator

Anneke Hesseling CTU Principal Investigator

Donna Germuga DAIDS PO

Maria Groenewald Investigator

Barbara Laughton Investigator

Simon Schaaf Investigator

Gerhard Theron Investigator

Lindie Rossouw Pediatrician

Catherine Andrea Pharmacist

Marlize Smuts Pharmacist of Record

Marjie van Schalkwyk Principal Investigator

Lilly Hoorn Research Nurse

Andrea Gutschmidt Staff

Sharifah Sylvester Staff

Marjie van Schalkwyk Study Coordinator

Studies at this Site

1077FF: PROMISE 1077FF

DAIDS Number

10778

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children

DAIDS Number

11831

Research Area

Treatment

Study Status

Concluded

P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls

DAIDS Number

11878

Research Area

Brain and Mental Health

Study Status

Participants Off Study and Primary Analysis Completed

P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants

DAIDS Number

11882

Research Area

Therapeutics

Study Status

Closed to Follow Up

P1110: Safety and PK of RAL in Neonates

DAIDS Number

11891

Research Area

Treatment

Study Status

Concluded

P1112: Monoclonal Antibody PK Study

DAIDS Number

11903

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2010: VESTED

DAIDS Number

30129

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2019: Phase I/II Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less than 12 Years of Age

DAIDS Number

38504

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

DAIDS Number

38609

Research Area

Therapeutics

Study Status

Enrolling